|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shin JY, Yoon JK and Marwaha G: Progress
in the treatment and outcomes for early-stage non-small cell lung
cancer. Lung. 196:351–358. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vargas AJ and Harris CC: Biomarker
development in the precision medicine era: Lung cancer as a case
study. Nat Rev Cancer. 16:525–537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Inage T, Nakajima T, Yoshino I and
Yasufuku K: Early lung cancer detection. Clin Chest Med. 39:45–55.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen J, Wang R, Zhang K and Chen LB: Long
non-coding RNAs in non-small cell lung cancer as biomarkers and
therapeutic targets. J Cell Mol Med. 18:2425–2436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bian C, Yuan L and Gai H: A long
non-coding RNA LINC01288 facilitates non-small cell lung cancer
progression through stabilizing IL-6 mRNA. Biochem Biophys Res
Commun. 514:443–449. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Luo X, Liu Y, Han G and Sun D:
Long noncoding RNA RMRP promotes proliferation and invasion via
targeting miR-1-3p in non-small-cell lung cancer. J Cell Biochem.
120:15170–15181. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang H, Han X, Li M, Li T and Hao Y:
Linc00221 modulates cisplatin resistance in non-small-cell lung
cancer via sponging miR-519a. Biochimie. 162:134–143. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Hu J, Li J, Yang Q, Hao M and Bu
L: Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer
progression through sponging miR-218-5p/PDCD4. Artif Cells Nanomed
Biotechnol. 47:1595–1602. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu X, Duan L, Liu H and Zhang L: Long
noncoding RNA LINC01296 induces non-small cell lung cancer growth
and progression through sponging miR-5095. Am J Transl Res.
11:895–903. 2019.PubMed/NCBI
|
|
14
|
Solé C and Lawrie CH: MicroRNAs and
metastasis. Cancers (Basel). 12:962019. View Article : Google Scholar
|
|
15
|
Deng H, Xie C, Ye Y and Du Z:
MicroRNA-1296 expression is associated with prognosis and inhibits
cell proliferation and invasion by Wnt signaling in non-small cell
lung cancer. Oncol Lett. 19:623–630. 2020.PubMed/NCBI
|
|
16
|
Zhou X, Liu S, Liu J, Zhang Z, Mao X and
Zhou H: MicroRNA-130a enhances the killing ability of natural
killer cells against non-small cell lung cancer cells by targeting
signal transducers and activators of transcription 3. Biochem
Biophys Res Commun. 523:481–486. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan L, Zhang Y, Li K, Wang M, Li J, Qi Z,
Wu J, Wang Z, Ling L, Liu H, et al: miR-593-5p inhibit cell
proliferation by targeting PLK1 in non small cell lung cancer
cells. Pathol Res Pract. 216:1527862020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qu CX, Shi XC, Zai LQ, Bi H and Yang Q:
LncRNA CASC19 promotes the proliferation, migration and invasion of
non-small cell lung carcinoma via regulating miRNA-130b-3p. Eur Rev
Med Pharmacol Sci. 23 (Suppl 3):S247–S255. 2019.
|
|
19
|
Wang X, Yin H, Zhang L, Zheng D, Yang Y,
Zhang J, Jiang H, Ling X, Xin Y, Liang H, et al: The construction
and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small
cell lung cancer. J Thorac Dis. 11:1772–1778. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li H, Guo X, Li Q, Ran P, Xiang X, Yuan Y,
Dong T, Zhu B, Wang L, Li F, et al: Long non-coding RNA 1308
promotes cell invasion by regulating the miR-124/ADAM 15 axis in
non-small-cell lung cancer cells. Cancer Manag Res. 10:6599–6609.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Meng W and Cui H: LncRNA CBR3-AS1
predicts unfavorable prognosis and promotes tumorigenesis in
osteosarcoma. Biomed Pharmacother. 102:169–174. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Cho KB, Li Y, Tao G, Xie Z and Guo
B: Long noncoding RNA (lncRNA)-mediated competing endogenous RNA
networks provide novel potential biomarkers and therapeutic targets
for colorectal cancer. Int J Mol Sci. 20:57582019. View Article : Google Scholar
|
|
24
|
Patil SL, Palat A, Pan Y, Rajapakshe K,
Mirchandani R, Bondesson M, Yustein JT, Coarfa C and Gunaratne PH:
MicroRNA-509-3p inhibits cellular migration, invasion, and
proliferation, and sensitizes osteosarcoma to cisplatin. Sci Rep.
9:190892019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niu L, Ni H, Hou Y, Du Q and Li H:
miR-509-3p enhances platinum drug sensitivity in ovarian cancer.
Gene. 686:63–67. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen W, Du J, Li X, Su J, Huang Y, Ding N,
Zhang M and Jiang S: miR-509-3p promotes cisplatin-induced
apoptosis in ovarian cancer cells through the regulation of
anti-apoptotic genes. Pharmacogenomics. 18:1671–1682. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun J, Li J, Zhang W, Zhang J, Sun S, Li
G, Song H and Wan D: MicroRNA-509-3p inhibits cancer cell
proliferation and migration via upregulation of XIAP in gastric
cancer cells. Oncol Res. 25:455–461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang L, Wang T, Zhang Y, Zhang J, Zhao H,
Wang H, Wu Y and Liu K: Long non-coding RNA AWPPH promotes
postoperative distant recurrence in resected non-small cell lung
cancer by upregulating transforming growth factor beta 1 (TGF-β1).
Med Sci Monit. 25:2535–2541. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bai Y, Zhang G, Chu H, Li P and Li J: The
positive feedback loop of lncRNA DANCR/miR-138/Sox4 facilitates
malignancy in non-small cell lung cancer. Am J Cancer Res.
9:270–284. 2019.PubMed/NCBI
|
|
30
|
Wang D and Hu Y: Long non-coding RNA PVT1
competitively binds microRNA-424-5p to regulate CARM1 in
radiosensitivity of non-small-cell lung cancer. Mol Ther Nucleic
Acids. 16:130–140. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu L, Zhu H, Gao F, Tang Y, Zhu Y, Sun Z
and Wang J: Upregulation of the long non-coding RNA CBR3-AS1
predicts tumor prognosis and contributes to breast cancer
progression. Gene X. 2:1000142019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ogunwobi OO and Kumar A: Chemoresistance
mediated by ceRNA networks associated with the PVT1 locus. Front
Oncol. 9:8342019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma Z, Liu D, Di S, Zhang Z, Li W, Zhang J,
Xu L, Guo K, Zhu Y, Li X, et al: Histone deacetylase 9
downregulation decreases tumor growth and promotes apoptosis in
non-small cell lung cancer after melatonin treatment. J Pineal Res.
67:e125872019. View Article : Google Scholar : PubMed/NCBI
|
